Cargando…
Adrenocorticotropic hormone analog use for podocytopathies
BACKGROUND: Adrenocorticotropic hormone is being increasingly studied for treatment of various glomerulopathies, most notably membranous nephropathy. Less data are available regarding its use in idiopathic nephrotic syndrome (INS) secondary to minimal change disease (MCD) or focal segmental glomerul...
Autores principales: | Filippone, Edward J, Dopson, Shirley J, Rivers, Denise M, Monk, Rebeca D, Udani, Suneel M, Jafari, Golriz, Huang, Solomon C, Melhem, Arafat, Assioun, Bassim, Schmitz, Paul G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935005/ https://www.ncbi.nlm.nih.gov/pubmed/27418857 http://dx.doi.org/10.2147/IMCRJ.S104899 |
Ejemplares similares
-
Podocytopathy
por: Agarwal, Sanjay K.
Publicado: (2016) -
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012) -
Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021) -
Defining diagnostic trajectories in patients with podocytopathies
por: Cirillo, Luigi, et al.
Publicado: (2022) -
Modeling Podocyte Ontogeny and Podocytopathies with the Zebrafish
por: Drummond, Bridgette E., et al.
Publicado: (2023)